Versameb is a Swiss based biotechnology platform company focusing on the optimized local delivery of therapeutic proteins.
Versameb has achieved preclinical proof of concept in different injury models by showing a significant acceleration of tissue regeneration after injuries.
Versameb has a novel proprietary technology platform for optimized and tailored, local delivery of therapeutic proteins.
Versameb has operationally started begin of 2018. We are happy about what we do and to share it with you.